Partner With Us NRI

Jubilant Ingrevia Ltd share Price

Company details

6M Return 23.58%
1Y Return -5.02%
Mkt Cap.(Cr) 7,509.30
Volume 82,436
Div Yield 1.06%
OI Chg %
Volume 82,436

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Specialty chemicals company Jubilant Ingrevia announced Q1FY24 results:

  • Q1FY24 vs Q1FY23:
    • Total revenue: Rs 1,075 crore vs Rs 1,166 crore, down 8% YoY
    • Total EBITDA: Rs 125 crore vs Rs 151 crore, down 17% YoY
    • EBITDA margin (%): 11.6% vs 12.9%
    • Profit after tax: Rs 58 crore vs Rs 79 crore, down 27% YoY
    • Profit after tax margin (%): 6.8% vs 5.4%
    • Basic & diluted EPS: Rs 3.6 vs Rs 5, down 27% YoY

Commenting on the Company’s performance, Shyam S Bhartia, Chairman and Hari S Bhartia, Co-Chairman, Jubilant Ingrevia,  said: “We are pleased to announce stable performance in Q1FY24, given the backdrop of depressed market conditions specifically in Agrochemical end-use markets.

In our specialty chemicals business, demand from our agrochemical customers globally continues to face headwinds due to exceptionally higher pipeline inventories. However, demand from our Pharmaceutical and other customers has improved leading to improved price realization and margins from these products including CDMO.

In our Nutrition & Health Solution Business, Niacinamide sales volumes improved significantly, resulting into revenue growth. We continue to witness improved price realisation due to higher demand in the segment. Businesses continue to maintain the global leadership position in Niacinamide and focus on Niche segments like Food & Cosmetics.

In our Chemical Intermediates Business, we continue to improve our market share of key product Acetic Anhydride, despite the challenges of lower demand from the agrochemical end-use segment. We also witnessed lower price realisation in the segment due to pricing pressure from the agro end-use of Acetic Anhydride and lower realisation of Ethyl Acetate in the export market.

We are witnessing softening of coal prices and with that, our overall energy cost is expected to normalise.

We remain committed towards our growth plans and are confident that our well-defined capex plan will deliver structured growth in the future as planned.”



Result PDF

View Other Company Results


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Jubilant Ingrevia Ltd Stocks COMPARISION


Equity Capital: 2,666.24 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 19,065.79 -9,437.36
LAST 3M 48,885.55 -453.72
LAST 6M 53,246.77 148,781.31
LAST 12M 137,184.48 160,910.46

Jubilant Ingrevia Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
  • Jubilant Ingrevia Limited (Formerly known as Jubilant LSI Limited) was incorporated as a Public Limited Company on 23 October 2019 in Uttar Pradesh. The name of Company was changed from `Jubilant LSI Limited` to `Jubilant Ingrevia Limited` effective October 16, 2020. The Company is a global integrated Life Science products and Innovative Solutions provider serving Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. The Company is a part of the Jubilant Bhartia Group, a diversified global conglomerate founded by Mr. Shyam S. Bhartia and Mr. Hari S. Bhartia. Today, the Group has a strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services. The Group has four flagships companies listed on Indian Stock Exchanges - Jubilant Ingrevia Limited, Jubilant Pharmova Limited, Jubilant FoodWorks Limited and Jubilant Industries Limited. The Company`s state-of-the-art manufacturing facilities across India offer a range of products and solutions that are innovative, cost effective and quality driven. It established itself as a single point solution for CDMO services for global Pharmaceutical and Agrochemical companies. It is at present across the value chain like Route design, Process Development, Process Optimisation, Scale-up and Commercial Manufacturing of Advance Intermediates for Pharma and Agro and Actives for Agrochemicals. It is a leading supplier of Ethanol to Oil Marketing Companies (OMCs) for Ethanol Blending Programme (EBP) among standalone distilleries in India. The Company is engaged in manufacturing and supply of speciality intermediates, nutrition & health solutions and life science chemicals through five manufacturing facilities in India. It offers broad portfolio of high quality ingredient that find application in a wide range of industries. It serves more than 1400 customers in more than 60 countries across the world. The portfolio of the Company is extended to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. The business focuses on three core segments - Speciality Chemicals, Nutrition and Health Solutions and Life Science Chemicals. The Company offer a range of products including straight Nutritional Ingredients like Vitamin B3, Picolinates to premix solutions for animal and human nutrition. The Life Science Chemicals and Speciality Chemicals segments provide complete backward integration giving competitive edge over competitors. The Company is the global largest producer of Niacinamide and amongst Global top two manufacturers of Vitamin B3 and India`s largest manufacturer of Vitamin B4. The Company is a `Partner of Choice` for more than 400 global customers. It has also embarked on the manufacturing of herbal range of products for animal feed under the brand `Phytoshield`. The Life Science Ingredients (LSI) business of Jubilant Pharmova Limited was demerged into the Company, (Jubilant Ingrevia Limited) through the Scheme of Amalgamation effective from February 1, 2021. Pursuant to Composite Scheme of Arrangement, 5 subsidiary companies of Jubilant Pharmova Limited namely, Jubilant Infrastructure Limited, Jubilant Life Sciences (USA) Inc., Jubilant Life Sciences International Pte. Limited, Jubilant Life Sciences (Shanghai) Limited and Jubilant Life Sciences NV became subsidiaries of the Company effective from the said date. During FY 2022-23, the Company acquired 37.98% of equity share capital of Mister Veg Foods Private Limited (MVFPL) effective March 16, 2023. It commissioned the 25,000 TPA New Acetic Anhydride Plant in Bharuch, Gujarat.

Registered Address

Bhartiagram, Gajraula, Amroha, Uttar Pradesh, 244223

Tel : 91-120-4361000
Email : deepanjali.gulati:jubl.com
Website : http://www.jubilantingrevia.com

Alankit Assignments Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 543271
Book Closure Date (Month) :
BSE Group : A
ISIN : INE0BY001018

FAQ’s on Jubilant Ingrevia Ltd Shares

You can buy Jubilant Ingrevia Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Jubilant Ingrevia Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Sep 27, 2023 01:44 PM the closing price of Jubilant Ingrevia Ltd was ₹ 471.45.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Sep 27, 2023 01:44 PM, the market cap of Jubilant Ingrevia Ltd stood at ₹ 7,509.30.

The latest PE ratio of Jubilant Ingrevia Ltd as of Sep 27, 2023 01:44 PM is 26.3

The latest PB ratio of Jubilant Ingrevia Ltd as of Sep 27, 2023 01:44 PM is 0.35

The 52-week high of Jubilant Ingrevia Ltd is ₹ 592.60 while the 52-week low is ₹ 350.45

Download Our App

market app
market app